USPTO serial 77833273
AGILENT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 17, 2012
- Examiner
- ROSSMAN, WILLIAM M
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with AGILENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew Roppel
Andrew Roppel Holland & Hart LLPP.O. Box 8749Denver, CO 80201-8749UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | House mark for a full line of reagents for scientific or medical research use; house mark for a full line of chemicals for scientific purposes used in spectroscopy, mass spectrometry, chromatography and electrophoresis and for sample preparation for spectroscopy, mass spectrometry, chromatography and electrophoresis; chemicals used in industry and science, namely, for use in spectroscopy, mass spectrometry, chromatography, or electrophoresis or in sample preparation for spectroscopy, mass spectrometry, chromatography, or electrophoresis including standards all for scientific, clinical and scientific research use; reagents for scientific and research use; aqueous and organic solvents in the nature of chemical preparations for scientific and research use; cleaning detergents for industrial use, namely, for scientific and research use; chemicals for scientific purposes, namely, calibrants for performance verification of scientific instrumentation; ampholytes, namely, chemical products in the nature of preparations for scientific use for use in the separation and purification of any charge carrying molecule such as proteins and other molecules of biological origin as well as synthetic chemicals, these products being carrier ampholytes designed for use in isoelectric focusing, isotachophoresis and iso exchange chromatograph; chemicals, namely, buffer and standard solutions used in analytical chemistry; catalysts for chemical and biochemical processes; reagents, namely, matrices for scientific or medical research use; electrophoresis gels other than for medical or veterinary purposes; chromatography chemicals, namely, silica gel, polymers and solvents all for use in chromatography; purifying filtering and absorbing chemicals for use in industry, including for scientific and research use; solid phase extraction chemicals for use in the chromatography industry; chemical and biological standards, namely, chemical reagents for scientific and research use used in DNA, RNA and protein analysis; reagents for research purposes for scientific or medical research use; DNA labeling reagents for research purposes; DNA hybridization buffers, namely, reagents for research purposes for use in DNA hybridization; DNA cloning vectors, namely, reagents for scientific and research use; genomic cloning vectors, namely, reagents for scientific and research use; eukaryotic expression vectors, namely, reagents for scientific and research use; prokaryotic expression vectors, namely, reagents for scientific and research use; yeast shuttle vectors, namely, reagents for scientific and research use; competent cells, namely, reagents for scientific and research use; host cells, namely, reagents for scientific and research use; scientific and research laboratory reagents for molecular biological use, namely, packaging extracts used for inserting DNA into phages; polymerase chain reaction or PCR related products, namely, reagents for scientific and research use; nucleic acid markers, namely, reagents for scientific and research use; reagents used as protein standards for scientific, medical and research use; reagents used as synthetic peptide and protein digest standards for scientific and research use; reagents, namely, DNA primers and DNA vectors for scientific and research use; modifying enzymes not for medical use, namely, polymerase, nucleases, reverse transcriptases, ligases, kinases, phosphatases, glycosylases and transferases for scientific and research use; restriction enzymes for scientific and research use; media supplements, namely, reagents for scientific and research use; [ lymphokines, namely, reagents for scientific and research use; ] cytokines, namely, reagents for scientific and research use; kits for molecular biological research, namely, DNA cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, genomic cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transfection kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, purification kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, polymerase chain reaction or PCR related cloning kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, ligase chain reaction or LCR kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, library construction kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, labeling kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, mutagenesis kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for scientific and research use, namely, protein analysis kits said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, transcription kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; kits for molecular biological research, namely, translation kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors; and kits for molecular biological research, namely, in situ hybridization kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors | ACTIVE | — |
| 003 | polishing powder | ACTIVE | — |
| 004 | lubricating oil and grease for vacuum pumps | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Agilent Technologies, Inc.
- Other trademarks owned by Agilent Technologies, Inc.
- Other trademarks owned by Agilent Technologies, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 004
- Similar marks named AGILENT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 24, 2022 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Jun 24, 2022 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jun 24, 2022 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Jun 24, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 23, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 23, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 23, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 18, 2022 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jan 28, 2021 | NOSU | NOTICE OF SUIT | — |
| Jan 17, 2021 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Aug 25, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 25, 2020 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Aug 25, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 25, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 8, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 8, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 8, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 8, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 4, 2017 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 4, 2017 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| May 4, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 16, 2017 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jan 17, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 17, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 1, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 1, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 23, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 15, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 15, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 6, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 3, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2011 | ALIE | ASSIGNED TO LIE | — |
| Jan 26, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 26, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 28, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2009 | NWAP | NEW APPLICATION ENTERED | — |